Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Goldman Jonathan W and Dvorkin Mikhail and Chen Yuanbin and Kollaborációs szervezet: CASPIAN investigators and Losonczy György and Horváth Zsolt and Pajkos Gábor and Bogos Krisztina and Somfay Attila and Pápai Székely Zsolt and Sárosi Veronika and Fülöp Andrea and Laczó Ibolya and Kósa Judit and Telekes András and Csánky Eszter and Somogyiné Ezer Éva and Pápai Zsuzsanna (kollab. közrem.): Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
LANCET ONCOLOGY, 22 (1). pp. 51-65. ISSN 1470-2045 (2021)

[thumbnail of 1-s2.0-S1470204520305398-main.pdf] Text
1-s2.0-S1470204520305398-main.pdf - Published Version
Closed access: Repository staff only

Download (2MB) | Request a copy
Item Type: Journal Article
Szerzők száma: 228
Journal or Publication Title: LANCET ONCOLOGY
Date: 2021
Volume: 22
Number: 1
Page Range: pp. 51-65
ISSN: 1470-2045
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 31810953
DOI azonosító: https://doi.org/10.1016/S1470-2045(20)30539-8
Date Deposited: 2024. Mar. 27. 08:58
Last Modified: 2024. Mar. 27. 08:58
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/29976
Web of Science® Times Cited: 346 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year